DGMT CTP ecNGS supplies

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$25,000 to $250,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Department of Health and Human Services Food and Drug Administration (FDA) is forecasting a new requirement contract for DGMT CTP ecNGS supplies, project E07877.01, categorized under Biological Product Manufacturing (NAICS 325414). The estimated solicitation release date is February 1, 2026, with an anticipated contract award date of April 1, 2026. This procurement appears to be focused on specialized scientific supplies related to next-generation sequencing (ecNGS) for the FDA's Center for Biologics Evaluation and Research.

While specific award values and precise quantities are not detailed in the forecast, the contract opportunity involves biological product supplies and will be managed through the FDA. Two points of contact have been identified: Joshua Holliday (joshua.holliday@fda.hhs.gov), a federal government representative, and a generic FDA mailbox (tbd@fda.gov). The procurement is not set aside for any specific small business category, indicating it may be open to a broad range of qualified manufacturers and suppliers in the biological product manufacturing sector.

Forecast text

DGMT CTP ecNGS supplies project E07877.01

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast